Early Identification and Prognostic Implications in Disseminated Intravascular Coagulation through Transmittance Waveform Analysis

Summary

Efforts to improve the prognosis in disseminated intravascular coagulation (DIC) have been hampered by the lack of an early, useful and rapidly available diagnostic marker. More recently, a characteristic bi-phasic change in the light transmittance waveform profile of the APTT assay has been associated with DIC. In this prospective study, we have assessed the utility of this assay in the routine clinical setting. 1,470 samples were analysed from 747 patients and 41 patients had DIC. The sensitivity and specificity of the bi-phasic waveform pattern for DIC was 97.6% and 98% respectively. The appearance of a biphasic waveform preceded the development of abnormalities in the standard laboratory tests for DIC and waveform changes correlated closely with clinical events. In conclusion, transmittance waveform analysis is not only useful as an early diagnostic and single monitoring marker of DIC but the quantifiable and standardisable changes also allow for prognostic applicability in clinical management.

• References

• 1 Spero JA, Lewis JH, Hasiba U. Disseminated intravascular coagulation: findings in 346 patients.. Thromb Haemost 1980; 43: 28-33.
• 2 Giles AR. Disseminated intravascular coagulation.. In: Haemostasis and Thrombosis.. Bloom A, Forbes C, Thomas D, Tuddenham E. eds. New York: Churchill Livingstone; 1994. pp 969-86.
• 3 Baglin T. Disseminated intravascular coagulation: diagnosis and treatment.. BMJ 1996; 312: 683-7.
• 4 Downey C, Kazmi R, Toh CH. Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation.. Br J Haematol 1997; 98: 68-73.
• 5 Feinstein DI. Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy.. Blood 1982; 60: 284-7.
• 6 Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee.. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.. Crit Care Med 1992; 20: 864-74.
• 7 Raimondi P, Bongard O, de Moerloose P, Reber G, Waldvogel F. D-Dimer plasma concentration in various clinical conditions.. Thromb Res 1993; 69: 125-30.
• 8 Lip GY, Lowe GD, Rumley A, Dunn FG. Increased markers of thrombo-genesis in chronic atrial fibrillation: effects of warfarin treatment.. Br Heart J 1995; 73: 527-33.